LGVN
Longeveron LLCNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$25.26M
P/E Ratio
—
EPS
$-1.30
Beta
-0.32
52W High
$1.80
52W Low
$0.47
50-Day MA
$0.89
200-Day MA
$0.81
Dividend Yield
—
Profit Margin
0.00%
Forward P/E
—
PEG Ratio
—
About Longeveron LLC
Longeveron Inc., a clinical-stage biotechnology company, is dedicated to developing cell therapies for life-threatening and aging-related conditions. The company is headquartered in Miami, Florida.
Fundamentals
| Revenue (TTM) | $1.20M |
| Gross Profit (TTM) | 803,000 |
| EBITDA | $-22.06M |
| Operating Margin | -1479.00% |
| Return on Equity | -164.70% |
| Return on Assets | -81.30% |
| Revenue/Share (TTM) | $0.07 |
| Book Value | $0.25 |
| Price-to-Book | 4.39 |
| Price-to-Sales (TTM) | 21.07 |
| EV/Revenue | 17.58 |
| EV/EBITDA | -49.61 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | -39.50% |
| Shares Outstanding | $27.80M |
| Float | $19.82M |
| % Insiders | 5.68% |
| % Institutions | 6.15% |
Analyst Ratings
Consensus ($5.48 target)
1
Strong Buy1
BuyMore HEALTHCARE Stocks
Data last updated: 5/5/2026